Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection

Previous studies on the immunogenicity of SARS‐CoV‐2 mRNA vaccines showed a reduced seroconversion in cancer patients. The aim of our study is to evaluate the immunogenicity of two doses of mRNA vaccines in solid cancer patients with or without a previous exposure to the virus. This is a single‐inst...

Descripción completa

Detalles Bibliográficos
Autores principales: La Verde, Nicla, Riva, Agostino, Cona, Maria Silvia, Gabrieli, Arianna, Cattaneo, Monica, Fasola, Cinzia, Lipari, Giuseppe, De Stradis, Claudia, Favorito, Valentina, Lombardi Stocchetti, Benedetta, Chizzoniti, Davide, Covizzi, Alice, Rulli, Eliana, Galli, Francesca, Ruggieri, Lorenzo, Gambaro, Anna, Ferrario, Sabrina, Dalu, Davide, Tarkowski, Maciej S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Cancer Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538813/
https://www.ncbi.nlm.nih.gov/pubmed/36056571
http://dx.doi.org/10.1002/ijc.34273

Ejemplares similares

Ejemplares similares